22nd EUROPEAN NEPHROLOGY CONFERENCE

15-16 October, 2018, Warsaw, Poland

Urate-lowering therapy ameliorates kidney function in type 2 diabetes patients with hyperuricemia

Naohiko Ueno, Ueno Internal Medicine and Diabetes Clinic

---

6th CENTRAL EUROPEAN CONGRESS ON OBESITY 5-7 October, 2017, Bratislava, Slovakia

The effect of mexiletine on body weight in type 2 diabetes patients with visceral obesity

Naohiko Ueno, Ueno Internal Medicine and Diabetes Clinic

---

4th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome  3-6 March, 2016, Venice, Italy

“Effect of uric acid lowering therapy on kidney function in type 2 diabetes patients.”

Naohiko Ueno, Ueno Internal Medicine and Diabetes Clinic

---

第22回欧州肥満学会　2015 May 6^th, Prague, Czech Republic

“The effect of Pioglitazone in addition to DPP-4 inhibitors on type 2 diabetes patients with non-alcoholic fatty liver disease.”

Naohiko Ueno

Ueno Internal Medicine and Diabetes Clinic

---

第21回欧州肥満学会　2014 May 28^th, Sofia, Bulgaria

“Evaluation of glucose transporters (GLUT1 & GLUT4) and UCP1 expression in brown　adipose tissue in short term-fasted rAAV-leptin treated mice.”

^1,2N. Ueno, ²A. Asakawa, ²A. Inui

¹Ueno Internal Medicine and Diabetes Clinic,

²Department of Psychosomatic Medicine, Kagoshima University Graduate School of Medical and Dental Sciences

---

第20回欧州肥満学会　2013 May 12^th, Liverpool, England

“Leptin is responsible for maintaining blood glucose levels and energy expenditure in fasting.”

^1,2N. Ueno, ²A. Asakawa, ²A. Inui

¹Ueno Internal Medicine and Diabetes Clinic,

²Department of Psychosomatic Medicine, Kagoshima University Graduate School of Medical and Dental Sciences

---

the 4th International Congress on Prediabetes & the Metabolic Syndrome  2011 April 6^th, Madrid, Spain

“The effect of atenolol on hypertension in metabolic syndrome.”

N. Ueno, Y. Satoh

Department of Internal Medicine, Kobe Mariners Hospital

---

第46回欧州糖尿病学会　2010 September 20^th, Stockholm, Sweden

“Paradoxical response in feeding in short-time fasted rAAV-leptin treated mice.”

^1,2N. Ueno, ²A. Asakawa, ²A. Inui

¹Ueno Internal Medicine and Diabetes Clinic,

²Department of Psychosomatic Medicine, Kagoshima University Graduate School of Medical and Dental Sciences

---

第45回欧州糖尿病学会　2009 May 13^th, Vienna,Austria

“The effect of atenolol on hypertension in metabolic syndrome.”

N. Ueno, Y. Satoh

Department of Internal Medicine, Kobe Mariners Hospital

---

第15回欧州肥満学会　2008 May 14^th, Geneva, Switzerland

“Blunted metabolic response to fasting in obese mice.”

^1,2N. Ueno, ²A. Asakawa, ²A. Inui

¹Ueno Internal Medicine and Diabetes Clinic,

²Department of Psychosomatic Medicine, Kagoshima University Graduate School of Medical and Dental Sciences

---

第14回欧州肥満学会　2007 April 22^nd, Budapest, Hungary

“Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide.”

¹N. Ueno, ²A. Asakawa, ¹Y. Satoh, ²A. Inui

¹Department of Internal Medicine, Kobe Seaside Hospital

²Department of Psychosomatic Medicine, Kagoshima University Graduate School of Medical and Dental Sciences

---

第42回欧州糖尿病学会　2006 Sept.14^th, Copenhagen, Denmark

“Effect of nighttime administration of mosapride, HT-4 receptor agonist, on overnight fasted blood glucose levels in type-2 diabetic patients.”

N. Ueno, Y. Satoh

Department of Internal Medicine, Kobe Mariners Hospital

---

第7回欧州内分泌学会　2005 Sept. 3^rd, Goteborg, Sweden

“A motilin agonist, erythromycin, decreases circulating growth hormone levels in normal subjects but not in diabetic subjects.”

¹N. Ueno,   ¹M. Uemoto ,   ³Y. Komatsu,   ²Y. Sato,   ¹A. Inui

¹Division of Diabetes, Digestive and Kidney Diseases, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine

²Department of Internal Medicine, Kobe Mariners Hospital

³Department of Internal Medicine, Komatsu Hospital

---

第12回国際内分泌学会　2004 August 31^st, Lisbon, Portugal

“Acute body weight regulation by fasting in lean and obese mice.”

N. Ueno, A. Asakawa, A Inui

Division of Diabetes, Digestive and Kidney Diseases, Department of

Clinical Molecular Medicine, Kobe University Graduate School of Medicine